p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study (2023)
Attributed to:
Evaluating new healthcare technologies in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cjp2.311
PubMed Identifier: 36948887
Publication URI: http://europepmc.org/abstract/MED/36948887
Type: Journal Article/Review
Parent Publication: The Journal of Pathology: Clinical Research
Issue: 3
ISSN: 2056-4538